retatrutide for type 1 diabetes Helped Adults With or Heart Disease Lose Up to 20 Percent of Their Weight, Study Finds How does Retatrutide (glucagon receptor

A 2025 systematic review and meta-analysis in Reviews in Endocrine and Metabolic Disorders found that tirzepatide (the active ingredient in Mounjaro and Zepbound) reduced hsCRP by approximately 33% and IL-6 by approximately 18% compared to placebo across patients with and without diabetes. A growing body of research suggests this effect occurs through direct action on the NF-B pathway, a master switch of inflammation

Photosynthetica 55 , 5057 (2017)

Importantly, controlled human data are largely limited to short-term experimental studies

The two compounds interact with different receptors that regulate growth hormone release from the pituitary gland